HIRSCHMAN ORIN 13D/13G Filings for Coya Therapeutics, Inc. (COYA)

HIRSCHMAN ORIN 13D and 13G filings for Coya Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2025-02-10
08:35 am
Purchase		 2024-12-31 13G Coya Therapeutics, Inc.
COYA		 HIRSCHMAN ORIN 1,333,919
8.000%		 169,547increase
(+14.56%)		 Filing
2024-02-07
6:55 pm
Purchase		 2023-12-31 13G Coya Therapeutics, Inc.
COYA		 HIRSCHMAN ORIN 1,164,372
8.100%		 471,977increase
(+68.17%)		 Filing
2023-01-05
08:30 am
Purchase		 2022-12-29 13G Coya Therapeutics, Inc.
COYA		 HIRSCHMAN ORIN 692,395
7.200%		 692,395increase
(New Position)		 Filing